Development of a Novel Human Serum Albumin-Based Tool for Effective Drug Discovery: The Investigation of Protein Quality and Immobilization
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Balázs Kenéz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111Budapest, Hungary. Hauptthemen laut MEDLINE: Drug Discovery, Serum Albumin, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nemzeti Kutat?si, Fejleszt?si ?s Innovaci?s Alap, Magyar Tudom?nyos Akad?mia.
Abstract (Originalsprache)
The binding ability of human serum albumin (HSA) on active pharmaceutical ingredients (APIs) is one of the most important parameters in the early stages of drug discovery. In this study, an immobilized HSA-based tool was developed for the rapid and easy in vitro screening of API binding. The work explored the serious incompleteness in the identification of HSA used for in vitro screening published in the last five years. To mitigate this problem, a comprehensive analysis and immobilization studies were performed on the most used HSA types. Serious differences in the colloidal stability of HSAs and their API binding ability on a selected set of APIs were observed. HSAs were immobilized on magnetic nanoparticles with glutardialdehyde (GDA) or cyclohexyl-diglycidyl ether (CDGE) linkers, which have never been used for HSA immobilization before. The HSA-MNP-CDGE complexes achieved a higher immobilization yield and preserved API binding ability; however, the esterase-like enzymatic activity of HSA reduced significantly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111Budapest, Hungary.
- Department of Chemical and Environmental Process Engineering, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111Budapest, Hungary.
- Department of Pharmaceutical Chemistry, Semmelweis University, Hőgyes E. Street 7-9, H-1092 Budapest, Hungary.
- Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.
- Center for Pharmacology and Drug Research & Development, Semmelweis University, Üllői Street 26, H-1085Budapest, Hungary.
- Department of Physical Chemistry and Materials Science, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111Budapest, Hungary.
ORCID-Profile: Zsófia Molnár, Péter Horváth, Gábor Katona, Diána Balogh-Weiser
Förderung
- Nemzeti Kutat?si, Fejleszt?si ?s Innovaci?s Alap
- Magyar Tudom?nyos Akad?mia
Zitieren
APA
Kenéz, B., Koplányi, G., Decsi, B., Molnár, Z., Horváth, P., Katona, G., Balogh, G. T., & Balogh-Weiser, D. (2025). Development of a Novel Human Serum Albumin-Based Tool for Effective Drug Discovery: The Investigation of Protein Quality and Immobilization. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02136
Vancouver
Kenéz B, Koplányi G, Decsi B, Molnár Z, Horváth P, Katona G, et al. Development of a Novel Human Serum Albumin-Based Tool for Effective Drug Discovery: The Investigation of Protein Quality and Immobilization. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02136
BibTeX
@article{Kenz2025,
author = {Kenéz, Balázs and Koplányi, Gábor and Decsi, Balázs and Molnár, Zsófia and Horváth, Péter and Katona, Gábor and Balogh, György T and Balogh-Weiser, Diána},
title = {Development of a Novel Human Serum Albumin-Based Tool for Effective Drug Discovery: The Investigation of Protein Quality and Immobilization},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02136}
}
EUVIMED